| pubmed-article:12472793 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12472793 | lifeskim:mentions | umls-concept:C0035067 | lld:lifeskim |
| pubmed-article:12472793 | lifeskim:mentions | umls-concept:C0232804 | lld:lifeskim |
| pubmed-article:12472793 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12472793 | lifeskim:mentions | umls-concept:C2348535 | lld:lifeskim |
| pubmed-article:12472793 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12472793 | pubmed:dateCreated | 2002-12-10 | lld:pubmed |
| pubmed-article:12472793 | pubmed:abstractText | Prior studies of percutaneous transluminal renal artery angioplasty and stenting (PTRAS) for atherosclerotic renal artery stenosis (RAS) have shown that renal function is improved in about 25%, stabilizes in about 40%, but worsens in about 25% of patients. The factors predicting benefit remain controversial. We tested the hypothesis that the baseline glomerular filtration rate (GFR) predicts the changes in GFR and blood pressure (BP) after PTRAS. | lld:pubmed |
| pubmed-article:12472793 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12472793 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12472793 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12472793 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12472793 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:12472793 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:WilcoxChristo... | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:LonderoHugoH | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:RamosFelipeF | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:KotliarCarolC | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:AlvarezDaniel... | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:BaglivoHugoH | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:RafaellePablo... | lld:pubmed |
| pubmed-article:12472793 | pubmed:author | pubmed-author:SánchezRamiro... | lld:pubmed |
| pubmed-article:12472793 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12472793 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:12472793 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12472793 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12472793 | pubmed:pagination | 276-82 | lld:pubmed |
| pubmed-article:12472793 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:meshHeading | pubmed-meshheading:12472793... | lld:pubmed |
| pubmed-article:12472793 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12472793 | pubmed:articleTitle | Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. | lld:pubmed |
| pubmed-article:12472793 | pubmed:affiliation | Instituto de Cardiologia y Cirugia Cardiovascular (ICYCC), Fundación Favaloro, Buenos Aires, Argentina. framos@ffavaloro.org | lld:pubmed |
| pubmed-article:12472793 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12472793 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12472793 | lld:pubmed |
